DeutschNewstral
Article
The Times of India on 2021-12-30 21:30
Covaxin safe for kids: Bharat Biotech
Related news
- 'Bharat Biotech yet to apply for Covaxin approval by Canada'The Times of India
Bharat Biotech clarifies on COVAXIN usageThe Hindu- Bharat Biotech terminates Covaxin pact with Brazil partnersThe Times of India
- Slowing down Covaxin output across plants: Bharat BiotechThe Times of India
- Coronavirus | After SII, Bharat Biotech seeks DCGI approval for CovaxinThe Hindu
- Coronavirus | Bharat Biotech to make 6 crore Covaxin doses by JulyThe Hindu
- Coronavirus live updates | Bharat Biotech to make 6 crore Covaxin doses by JulyThe Hindu
- Bharat Biotech says COVID-19 vaccine Covaxin shows 81% interim efficacyThe Hindu
- Bharat Biotech releases Covaxin Phase-3 trial data, claims 77.8% efficacyThe Hindu
India’s Bharat Biotech says its Covaxin coronavirus vaccine is 81 per cent effectiveSouth China Morning Post- Ocugen pays $15 mn upfront to Bharat Biotech for Covaxin rights in CanadaThe Hindu
- COVID-19 vaccination | Use only Covaxin for 15-18 age cohort: Bharat BiotechThe Hindu
- Coronavirus | Covaxin trial participants could test positive, says Bharat BiotechThe Hindu
- No paracetamol, painkillers needed after Covaxin jab: Bharat BiotechThe Hindu
- Submitted all documents to WHO for EUL: Bharat BiotechThe Times of India
- Bharat Biotech cuts vaccine price for States to ₹400/doseThe Hindu
Emergency use listing for Bharat Biotech’s Covaxinherald.co.zw- Covaxin demonstrates robust safety and immunogenicity in children 2-18 years: Bharat BiotechThe Hindu
- Death of Bhopal volunteer not due to Covaxin, says Bharat BioTechThe Hindu
- Coronavirus | 130 Covaxin trial volunteers may test positive, says Bharat BiotechThe Hindu